Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat

IncHI2 Plasmids Are the Key Vectors Responsible foroqxABTransmission among Salmonella Species

(2016) Marcus Ho-yin Wong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evolution and Dissemination of OqxAB-Like Efflux Pumps, an Emerging Quinolone Resistance Determinant among Members of Enterobacteriaceae

(2015) Marcus Ho Yin Wong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to CiprofloxacinIn Vitro

(2013) T. Guillard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu

(2013) J. Dominguez-Herrera et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia

(2013) C.-H. Liao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification

(2012) Angeliki Mavroidi et al.   BMC INFECTIOUS DISEASES

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

(2012) J. S. Brooke   CLINICAL MICROBIOLOGY REVIEWS

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum  -lactamase-producing Escherichia coli

(2012) N. Lampri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model

(2012) L. Jakobsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes

(2010) Yong Pil Chong et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece

(2010) I. Galani et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection

(2009) N. Allou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat

(2009) J. Strahilevitz et al.   CLINICAL MICROBIOLOGY REVIEWS

Emergence of the Plasmid-Mediated Quinolone Resistance Gene qnrS1 in Escherichia coli Isolates in Greece

(2008) O. Vasilaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period

(2008) H. B. Kim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasmid-Mediated Quinolone Resistance Pump QepA2 in an Escherichia coli Isolate from France

(2008) V. Cattoir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin

(2008) L. M. Cavaco et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes

(2007) Jin-Yong Jeong et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE